Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group

por Nielsen, Ole S., Dombernowsky, Per, Mouridsen, Henning, Daugaard, Søren, Van Glabbeke, Martine, Kirkpatrick, Anne, Verweij, Jaap
Publicado 2000

A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study...

por Bramwell, Vivien H. C., Burgers, Marion V., Souhami, Robert L., Taminiau, Antonie H. M., Van Der Eijken, Jan W., Craft, Alan W., Malcolm, Archie J., Uscinska, Barbara, Kirkpatrick, Anna L., Machin, David, Van Glabbeke, Martine M.
Publicado 1997

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the Eur...

por McTiernan, Anne, Jinks, Rachel C., Sydes, Matthew R., Uscinska, Barbara, Hook, Jane M., van Glabbeke, Martine, Bramwell, Vivien, Lewis, Ian J., Taminiau, Antonie H.M., Nooij, Marianne A., Hogendoorn, Pancras C.W., Gelderblom, Hans, Whelan, Jeremy S.
Publicado 2012